← All stocks

Artiva Biotherapeutics, Inc.

ARTV Net buying
CIK 0001817241 #3037 in the set updated 17 Sep 2026
Bought (12 mo)
$109.12M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.94M
$449.39K on a plan · $103.88K straight out of an exercise
Sold at will
$1.39M
9 of 15 sales
Net
+$107.18M
+$107.73M against sales at will

By person

11 insiders · 36 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$92.62M (19)
+$92.62M
17,329,570
$189.17M
+99.3%
GC Corp. entity
10% owner
$16.50M (2)
+$16.50M
5,999,703
$65.49M
+31.4%
Aslan Fred
Chief Executive Officer
$1.38M (6)
−$1.38M
1,604,765
$17.52M
+640.7%
Banerjee Subhashis
Chief Medical Officer
$179.54K (4) scheduled
−$179.54K
170,947
$1.87M
Horan Christopher
Chief Tech Operations Officer
$178.71K (2)
−$178.71K
323,084
$3.53M
+1,192%
Bush Jennifer
COO, CLO, Compliance Officer
$172.78K (2)
−$172.78K
374,529
$4.09M
+414.5%
Raymon Heather
SVP, Research and Development
$27.88K (1)
−$27.88K
148,228
$1.62M
+1,382%
Huston Thad Allen
Chief Financial Officer
220,000
$2.40M
Miralles Gines Diego
President & Head of R&D
122,500
$1.34M
Krishnamohan Neha
Chief Financial Officer
99,356
$1.08M
+98.7%
Graef Thorsten
Chief Medical Officer
80,000
$873.26K
+300.0%

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 24,289,328 to 48,890,121 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Aslan Fred
8 Sep 2026
Chief Executive Officer
Sold on a plan
23,429
$10.92
$255.75K
Aslan Fred
3 Sep 2026
Chief Executive Officer
Sell
61,888
$11.16
$690.39K
Banerjee Subhashis
3 Sep 2026
Chief Medical Officer
Sell
1,100
$11.16
$12.27K
Bush Jennifer
3 Sep 2026
COO, CLO, Compliance Officer
Sell
8,391
$11.16
$93.61K
Horan Christopher
3 Sep 2026
Chief Tech Operations Officer
Sell
10,366
$11.16
$115.64K
Banerjee Subhashis
27 Aug 2026
Chief Medical Officer
Sold after exercise
8,222
$12.01
$98.74K
Banerjee Subhashis
18 Aug 2026
Chief Medical Officer
Sold after exercise
429
$12.00
$5.15K
RA CAPITAL MANAGEMENT, L.P.
31 Jul 2026
Director
Buy indirect
24,944
$9.93
$247.69K
RA CAPITAL MANAGEMENT, L.P.
29 Jul 2026
Director
Buy indirect
20,824
$9.99
$208.03K
RA CAPITAL MANAGEMENT, L.P.
24 Jul 2026
Director
Buy indirect
41,319
$9.99
$412.78K
RA CAPITAL MANAGEMENT, L.P.
23 Jul 2026
Director
Buy indirect
59,880
$9.96
$596.40K
RA CAPITAL MANAGEMENT, L.P.
22 Jul 2026
Director
Buy indirect
84,124
$9.93
$835.35K
RA CAPITAL MANAGEMENT, L.P.
21 Jul 2026
Director
Buy indirect
120,582
$9.55
$1.15M
RA CAPITAL MANAGEMENT, L.P.
17 Jul 2026
Director
Buy indirect
7,882
$8.95
$70.54K
RA CAPITAL MANAGEMENT, L.P.
16 Jul 2026
Director
Buy indirect
152,472
$8.93
$1.36M
RA CAPITAL MANAGEMENT, L.P.
13 Jul 2026
Director
Buy indirect
6,552
$8.94
$58.57K
RA CAPITAL MANAGEMENT, L.P.
10 Jul 2026
Director
Buy indirect
15,102
$8.97
$135.46K
RA CAPITAL MANAGEMENT, L.P.
26 Jun 2026
Director
Buy indirect
1,876
$8.98
$16.85K
RA CAPITAL MANAGEMENT, L.P.
25 Jun 2026
Director
Buy indirect
31,000
$8.88
$275.28K
RA CAPITAL MANAGEMENT, L.P.
16 Jun 2026
Director
Buy indirect
124,893
$8.89
$1.11M
RA CAPITAL MANAGEMENT, L.P.
15 Jun 2026
Director
Buy indirect
15,414
$8.99
$138.57K
RA CAPITAL MANAGEMENT, L.P.
12 Jun 2026
Director
Buy indirect
391,019
$8.57
$3.35M
RA CAPITAL MANAGEMENT, L.P.
11 Jun 2026
Director
Buy indirect
548,580
$7.91
$4.34M
RA CAPITAL MANAGEMENT, L.P.
10 Jun 2026
Director
Buy indirect
103
$7.00
$721.00
RA CAPITAL MANAGEMENT, L.P.
9 Jun 2026
Director
Buy indirect
479,039
$6.91
$3.31M
Aslan Fred
19 May 2026
Chief Executive Officer
Sell
27,116
$9.01
$244.25K
Banerjee Subhashis
19 May 2026
Chief Medical Officer
Sell
7,037
$9.01
$63.39K
Bush Jennifer
19 May 2026
COO, CLO, Compliance Officer
Sell
8,790
$9.01
$79.18K
Horan Christopher
19 May 2026
Chief Tech Operations Officer
Sell
7,002
$9.01
$63.07K
Raymon Heather
19 May 2026
SVP, Research and Development
Sell
3,095
$9.01
$27.88K
RA CAPITAL MANAGEMENT, L.P.
11 May 2026
Director
Buy indirect
6,510,416
$11.52
$75.00M
GC Corp.
11 May 2026
10% owner
Buy indirect
347,222
$11.52
$4.00M
GC Corp.
11 May 2026
10% owner
Buy
1,085,069
$11.52
$12.50M
Aslan Fred
15 Dec 2025
President and CEO
Sold on a plan
3,187
$6.00
$19.12K
Aslan Fred
17 Nov 2025
President and CEO
Sold on a plan
6,375
$3.38
$21.52K
Aslan Fred
17 Oct 2025
President and CEO
Sold on a plan
25,500
$6.00
$153.00K

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 2
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 2,534,096
History held since 22 Jul 2024